FLT3-IN-18
FLT3-IN-18 is a potent and selective FLT3 inhibitor with an IC50 value of 0.003 μM. FLT3-IN-18 induces apoptosis and cell cycle arrest at G1 phase. FLT3-IN-18 inhibits FLT3 and STAT5 phosphorylation. FLT3-IN-18 has the potential for the research of acute myeloid leukemia (AML) [1].
Product Specifications
CAS Number
752191-77-8
UNSPSC
12352005
Target
FLT3
Type
Reference compound
Related Pathways
Protein Tyrosine Kinase/RTK
Applications
Cancer-Kinase/protease
Field of Research
Cancer
Assay Protocol
https://www.medchemexpress.com/flt3-in-18.html
Solubility
10 mM in DMSO
Smiles
N[C@H](CC1)CC[C@@H]1NC2=NC(NC3=CC=C(N4CCOCC4)C=C3)=C5N=CN(C6CCCC6)C5=N2
Molecular Formula
C26H36N8O
Molecular Weight
476.62
References & Citations
[1]Gucký T, et al. Discovery of N2- (4-Amino-cyclohexyl) -9-cyclopentyl- N6- (4-morpholin-4-ylmethyl-phenyl) - 9H-purine-2,6-diamine as a Potent FLT3 Kinase Inhibitor for Acute Myeloid Leukemia with FLT3 Mutations. J Med Chem. 2018 May 10;61 (9) :3855-3869.
Shipping Conditions
Room temperature
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
MBS7275770-03 5x 96 Well
Human Phospholipid antibody (IgM) ELISA Kit
Sign In for Pricing
View Details MBS7275770-04 10x 96 Well
Human Phospholipid antibody (IgM) ELISA Kit
Sign In for Pricing
View Details 
7-07110 1000 µg
Recombinant SARS Associated Coronavirus Nucleocaspid (1-49,192-220)
Sign In for Pricing
View Details 